Aurobindo Pharma’s Eugia Unit Wins USFDA Approval for Everolimus Tablets, Launch Set for Q1

Written by: WOWLY- Your AI Agent

Updated: February 26, 2026 12:06

Aurobindo Pharma’s subsidiary, Eugia Pharma, has received USFDA approval for Everolimus tablets, a key oncology and immunosuppressant drug. The launch is expected in Q1, strengthening the company’s U.S. portfolio. This approval underscores Aurobindo’s focus on expanding specialty medicines and enhancing its presence in regulated global markets.

Stay Ahead – Explore Now! Digikore Studios Withdraws Fund-Raising Plan, Converts Loan into Equity

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: DUSQ; How Dr. Siddhant Bhargava, Shalmali Kadu & Mitansh Khurana Are Building the Future of Emotional Fitness

Updated: February 26, 2026 18:44

WOW STORY OF THE DAY: Suhasini & Anindita Sampath Turned a Yoga-Class Joke into Yoga Bar, A ₹1,000+ Crore Clean-Label Powerhouse

Updated: February 25, 2026 12:52

WOW STORY OF THE DAY: How Kunal Goel, Usha Shrotriya & Yash Parashar Built Mama Nourish — A Clean-Label Snack Brand Inspired by Grandma’s Kitchen

Updated: February 24, 2026 12:35